ArticleGynecologic oncology2019

Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041).

Jung-Yun Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.